Journal
mBio
Publication Date
1-25-2022
Volume
13
Issue
1
First Page
e0344221
Document Type
Open Access Publication
DOI
10.1128/mbio.03442-21
Rights and Permissions
Gonzalez Lopez Ledesma MM, Sanchez L, Ojeda DS, Oviedo Rouco S, Rossi AH, Varese A, Mazzitelli I, Pascuale CA, Miglietta EA, Rodríguez PE, Pallarés HM, Costa Navarro GS, Caramelo JJ, Rothlauf PW, Liu Z, Bloyet LM, Cornejo Pontelli M, Rasetto NB, Wenker SD, Ramis LY, Bialer MG, de Leone MJ, Hernando CE, Bianchimano L, Ríos AS, Treffinger Cienfuegos MS, Rodriguez García DR, Longueira Y, Laufer N, Alvarez D, Ceballos A, Ochoa V, Monzani C, Turk G, Salvatori M, Carradori J, Prost K, Rima A, Varela C, Ercole R, Toro RI, Gutierrez S, Zubieta M, Acuña D, Nabaes Jodar MS, Torres C, Mojsiejczuk L, Viegas M, Velazquez P, Testa C, Kreplak N, Yanovsky M, Whelan S, Geffner J, Pifano M, Gamarnik AV. Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time. mBio. 2022 Jan 25;13(1):e0344221. doi.org/10.1128/mbio.03442-21 Copyright © 2022 Gonzalez Lopez Ledesma et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Recommended Citation
Gonzalez Lopez Ledesma, María M; Rothlauf, Paul W; Liu, Zhuoming; Bloyet, Louis-Marie; Cornejo Pontelli, Marjorie; and et al, "Longitudinal study after Sputnik V vaccination shows durable SARS-CoV-2 neutralizing antibodies and reduced viral variant escape to neutralization over time." mBio. 13, 1. e0344221 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11815
